AUS
NZ
UK
CA
USA
IND
Healthcare
UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'
December 02, 2020 06:53 PM AEDT| By Team Kalkine MediaIn a major development, the United Kingdom on Wednesday became the first nation to approve the Pfizer-BioNTech vaccination for public use. The COVID-19 mRNA vaccine candidate will be rolled out from next week, informed UK health secretary Matt Hancoc...
GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments
November 10, 2020 03:33 PM AEDT| By Hina ChowdharyGE Healthcare is the healthcare division of the American multinational conglomerate, General Electric (NYSE: GE). The division alone is valued at US$16.7 billion and provides medical technology and related digital solutions on a global scale. .....
CLINUVEL’s Share Price Up ~9%, What Pushed the ASX 200 Healthcare Stock north?
September 10, 2020 07:10 PM AEST| By Team Kalkine MediaSummary ASX 200 company CLINUVEL PHARMACEUTICALS LTD disclosed the progression of SCENESSE® (afamelanotide 16 mg) for the treatment of xeroderma pigmentosum. Following the announcement CLINUVEL share price skyrocketed, ending the session at.....
Imugene Secures Option Underwriting Agreement with Bell Potter to Raise $5.7 Million
September 10, 2020 12:50 PM AEST| By Team Kalkine MediaNSW-headquartered clinical stage immuno-oncology firm, Imugene Limited (ASX:IMU) has secured an underwriting agreement with Bell Potter Securities Limited with institutional investors to underwrite the balance of options not exercised by 30 Novembe.....
SUDA Secures Australian Patent Office’s Approval on Anagrelide Cancer Patent
September 09, 2020 02:17 PM AEST| By Team Kalkine MediaSummary SUDA’s share price soared by ~12% on securing approval for anagrelide cancer patent in Australia. With the Australian Patent Office accepting the patent application, the anagrelide patent will now proceed to grant. The approval o.....
Imugene Attains First US Ethics Approval from WIRB to Begin PD1-Vaxx’s Phase I trial
September 08, 2020 12:59 PM AEST| By Team Kalkine MediaAustralia-based immuno-oncology company Imugene Limited (ASX:IMU) has recently marked a great leap forward by attaining the first ethics approval in the US to kick-start Phase I trial of new cancer immunotherapy, PD1-Vaxx. The approval has been rec.....
ASX 200 Biotech Major CSL Inks Two Deals to Manufacture COVID-19 Vaccines in Australia
September 07, 2020 05:57 PM AEST| By Team Kalkine MediaSummary Governments in several countries are securing early access of COVID-19 vaccine by signing deals with the frontrunners. ASX 200 biotech player, CSL Limited had signed two Heads of Agreement to manufacture and supply COVID-19 vaccine acro.....
ASX Share Price to Watch - Telix Pharmaceuticals; announces prostate cancer imaging partnership, receives ODD for TLX102
September 05, 2020 12:15 AM AEST| By Team Kalkine MediaSummary ASX-listed biopharmaceutical player Telix Pharmaceuticals announced a strategic collaboration agreement with Palo Alto-based Varian Medical Systems on 3 September. Through the collaboration, the two parties will evaluate the use of adva.....
Noxopharm to Commence Veyonda®’s Clinical Trial in COVID-19 Patients in Europe
September 04, 2020 01:45 PM AEST| By Team Kalkine MediaAustralian biotech, Noxopharm Limited (ASX:NOX) has announced an important milestone with formal approval for immediate initiation of Veyonda®’s clinical trial in COVID-19 patients in Europe. Following the key update, the Company’s.....
Starpharma bags A$1 million funding for COVID-19 spray - a shot in the arm for the ASX300 Player?
September 03, 2020 05:36 PM AEST| By Team Kalkine MediaSummary ASX 300 listed healthcare player Starpharma Holdings Limited receives A$1 million funding from MRFF for its SPL7013 COVID-19 nasal spray. The Company intends to utilise the funds to accelerate the development and commercialisation .....
Has the ASX 200 Healthcare Stock Mesoblast Touched a new 52-week high?
September 02, 2020 06:31 PM AEST| By Team Kalkine MediaSummary Australian regenerative medicine company Mesoblast’s share price hit a 52-week high on 27 August following outstanding FY2020 results with revenue up 92%. Mesoblast, on 2 September, received ethics approval to include Australian h.....
Imugene’s FY20 Report Card Out, Outlines Notable Operational Achievements
September 02, 2020 01:20 PM AEST| By Team Kalkine MediaIn a latest update, the biotech company Imugene Limited (ASX:IMU) has published its Annual Report for the year ended 30th June 2020 on the ASX. The financial year 2020 has been a remarkable one for Imugene, experiencing significant change and growt.....
COVID-19: What Drove ASX 300 listed Starpharma Share Price Today?
September 01, 2020 05:28 PM AEST| By Team Kalkine MediaSummary ASX 300 healthcare company Starpharma Holdings has applied its novel DEP® drug delivery technology to develop a long-acting, water-soluble formulation of remdesivir. Starpharma’s DEP® remdesivir is a water-soluble nanopart.....
Scan Through SUDA’s Key Operational Achievements in FY 2019-2020
August 31, 2020 08:29 PM AEST| By Team Kalkine MediaSummary SUDA reported key operational achievements for FY 2019-2020. The Company finalised a key agreement with Cann Pharma Australia during the year. The financial year also saw the signing of three significant agreements with Sanofi, Ordesa .....
Australian Cannabis Sector’s Growth Continues; Lens on Althea and MGC Pharmaceuticals
August 30, 2020 12:10 AM AEST| By Team Kalkine MediaThe Australian cannabis industry is growing continuously dodging the impact of COVID-19 pandemic. The cannabis industry in Australia will be able to export in the lucrative US market, Southeast Asia, China, and Canada markets, as the Australian gov.....
ASX 200 Pharma Player Set to Race into the Mighty US Market, With a COVID Kicker; Stock up 4.5x from March Lows
August 28, 2020 11:10 PM AEST| By Team Kalkine MediaA recent ASX200 entrant midcap pharma company, aggressively cutting costs as it prepares to take its drug RYONCIL™ into the mighty US healthcare market. Additionally, this drug is being evaluated in clinical trials against acute respiratory dis...
Why is ASX 200 listed AVITA Therapeutics share price up today despite reporting FY20 loss?
August 28, 2020 05:37 PM AEST| By Team Kalkine MediaSummary ASX 200 listed healthcare company AVITA Therapeutics reported FY20 revenue of US$14.263 million from RECELL Systems, up 161%. However, The Company reported a loss of US$42 million for the year ended 30 June 2020, due to an increase in o.....
5 Healthcare Share Prices Under Discussion Today - Starpharma, Ramsay, Mesoblast, Ansell, CLINUVEL
August 27, 2020 06:57 PM AEST| By Team Kalkine MediaThe current reporting season has been challenging for many sectors with the double whammy of bushfires and COVID-19 pandemic weighing down businesses. However, the ongoing market turmoil has created an opportunity for the healthcare sector. S.....
PTX Solidifies Balance Sheet Further: Announces A$7 million Placement to Support Expanded Pipeline of Innovative Cancer Therapies
August 26, 2020 07:51 PM AEST| By Team Kalkine MediaOn 26 August 2020, Prescient Therapeutics Limited (ASX:PTX) announced that it has received firm commitments to raise A$7,046,084 (before costs) by way of a share placement of 128,110,611 fully paid ordinary shares to professional as well as sophist.....
What’s defining the momentum for these ASX 300 listed healthcare share prices: IDX, NAN, ANN
August 26, 2020 12:00 AM AEST| By Team Kalkine MediaDuring the current reporting season, healthcare companies have reported impressive financial results amid the opportunities created by COVID-19 pandemic in the healthcare sector. The share price of ASX listed healthcare companies remains on watch a.....
Advertise your brand on Kalkine Media